Focus: Matrix Biomed is a gene therapy-focused biotechnology company headquartered in Irvine, CA, developing innovative treatments for oncology and rare diseases. The company operates at an early-to-mid stage with a pipeline concentrated in Phase 2 programs.
Profile data last refreshed 15h ago · AI intelligence enriched 1w ago
Matrix Biomed offers meaningful early-stage exposure to gene therapy oncology, but career viability depends on the company's ability to secure funding and advance Phase 2 programs without disruption.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Matrix Biomed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Matrix Biomed's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles